Petco and Klarna Make Pet Care More Accessible with “Pay in 4” Payment Services Online and In-Store

Petco is the first pet care brand to offer pet parents nationwide the option to split purchases into four interest-free payments at checkout

PR Newswire

SAN DIEGO, Aug. 5, 2021 /PRNewswire/ — Petco Health and Wellness Company, Inc. (Nasdaq: WOOF), a complete partner in pet health and wellness, and Klarna, a leading global retail bank, payments and shopping service, are partnering to offer Klarna’s Pay in 4 solution on petco.com, across Petco’s nearly 1,500 pet care centers nationwide, and the Klarna app. The new payment option makes caring for the whole health of pets more accessible and flexible, giving pet parents the option to split their purchase into four interest-free payments spread over the course of six weeks.

“Through the first quarter of this year, Petco generated strong double-digit growth and continued momentum by making complete pet care as easy, seamless, and accessible as possible – including helping pet parents support their pets’ wellness without stressing about cost,” said Petco Chief Digital and Innovation Officer Darren MacDonald. “With Klarna, we’re creating another avenue for pet parents to do just that, whether they’re welcoming a new family member, caring for a pet’s unique health needs, or restocking on the basics.”

The $119 billion pet category is poised to grow at an 8% CAGR over the next five years according to recent industry forecasts with higher growth projections in key areas like premium nutrition, services, vet, and digital where Petco is uniquely positioned. Millennials and Gen Zers, who have been spending more on their furry family members, not only represent the majority of recent growth, but 65% of 18- to 34-year-olds indicate they plan to acquire or add a pet in the next five years.

With seamless integration into the digital and physical shopping experience, Klarna provides another convenient payment method that removes financial barriers for pet parents prioritizing their pet’s health and wellness. The new Klarna payment option will be available starting later this year and can be applied to all purchases, including merchandise and services.* Pet parents utilizing Klarna’s flexible payment options will also still be eligible to earn rewards through their Pals Rewards account like any other purchase. 

“We’re excited to offer Petco to Klarna’s 18.5 million customers in North America, and to bring added payment flexibility to Petco’s existing ecommerce and brick and mortar customers,” said Klarna Head of North America David Sykes. “Consumers—especially Millennials and Gen Zers, many of whom are becoming pet parents for the first time—are turning away from traditional credit and demanding more flexible payment options. Klarna’s interest-free solutions increase consumers’ purchasing power, granting them the freedom to shop for and buy what they need, when they need it. At the same time, our brand partners benefit as average order values increase by 20-80% and conversions can climb by 20% or more.”

Klarna’s flexible payment options join a suite of shopping innovations Petco has introduced over the past eighteen months, including nationwide curbside pickup, same-day delivery, Vital Care, the revolutionary Petco Pay credit card program, and more.

For more information on Petco, visit petco.com. For more information on Klarna, visit klarna.com.

*Exclusions apply on recurring payments (Repeat Delivery and VitalCare), mobile vaccination clinics and partner veterinary hospitals. Klarna services will only be available to US-based Petco customers.

About Petco, The Health + Wellness Co.

Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. Since our founding in 1965, we’ve been striving to set new standards in pet care, delivering comprehensive wellness solutions through our products and services, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 Petco locations across the U.S., Mexico and Puerto Rico, including a growing network of more than 100 in-store veterinary hospitals, and offer a complete online resource for pet health and wellness at petco.com and on the Petco app. In tandem with Petco Love (formerly the Petco Foundation), an independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we’ve helped find homes for more than 6.5 million animals.

About Klarna
We make shopping smooth. With Klarna consumers can buy now and pay later, so they can get what they love today. Klarna’s offering to consumers and retailers include payments, social shopping, and personal finances. Over 250,000 retail partners, including H&M, IKEA, Expedia Group, Samsung, ASOS, Peloton, Abercrombie & Fitch, Nike and AliExpress have enabled Klarna’s innovative shopping experience online and in-store. Klarna is one of the most highly valued private fintechs globally with a valuation of $45.6 billion. Klarna was founded in 2005, has over 4,000 employees and is active in 17 countries. For more information, visit klarna.com.

Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are other than statements of historical fact. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct. Forward-looking statements are subject to many risks and uncertainties, including the risk factors that Petco identifies in its Securities and Exchange Commission filings, and actual results may differ materially from the results discussed in such forward-looking statements. Petco undertakes no duty to update publicly any forward-looking statement that it may make, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

Contacts:

For Petco:
Danielle Alvarado
[email protected]

For Klarna:
Adaline Colton
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-and-klarna-make-pet-care-more-accessible-with-pay-in-4-payment-services-online-and-in-store-301349479.html

SOURCE Petco Health and Wellness Company, Inc.

MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study

MyMD Pharmaceuticals’ Lead Compound MYMD-1 Shown to Suppress a Major Cause of Death in COVID-19 in Human Cell Study

  • MYMD-1 human cell research study demonstrates drug’s ability to target immune dysfunction and cytokine storm that leads to death from COVID-19
  • Phase 2 trial of MYMD-1 as a therapy for COVID-19-associated depression and cytokine elevation expected to begin by fourth quarter 2021; initial trial data expected in first quarter 2022

BALTIMORE, Md.–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, today announced that a human cell research study of lead clinical compound MYMD-1 found the drug to be effective in suppressing the cytokine storm, a major cause of severity and death in COVID-19 patients.

Accumulating evidence suggests that an increased level of inflammatory mediators, including cytokines, are associated with the severity of COVID-19.1 Cytokine storm causes an overreaction of the immune system that can cause the body to attack its own tissues and organs, leading to a high proportion of deaths from COVID-19.

“MYMD-1’s potential ability to stop one of the leading causes of death in COVID-19 is among the most exciting developments in our research to date,” said Chris Chapman, M.D., President, Director and Chief Medical Officer of MyMD. “MYMD-1 regulates the immuno-metabolic system by modulating numerous pro-inflammatory cell signaling molecules called cytokines. The primary cytokine that MYMD-1 inhibits is TNF-α (tumor necrosis factor alpha). MYMD-1 has been shown in laboratory tests of human cells to block TNF-α production – and the cytokine storm of COVID-19 that it produces – which have been implicated in causing injury and death from the coronavirus disease.

“MYMD-1 was first developed for the treatment of autoimmune and age-related diseases including extending human lifespan, but its mechanism of action offers potential therapeutic benefit for COVID-19 conditions,” Dr. Chapman continued.

“Along with our focus on extending healthy lifespan, treatment for COVID-19-related complications is now a cornerstone of our clinical development plan for MYMD-1.”

COVID-19 Associated Depression

MYMD-1 may also be effective as a therapy for COVID-19-associated depression. MyMD is collaborating with a major medical school for a Phase 2 clinical trial to investigate the effectiveness of MYMD-1 to treat immune mediated depression and cytokine elevation in patients affected with COVID-19. As a COVID-19-related therapy, MYMD-1 has the potential to move rapidly toward FDA approval through a special emergency program created to move new treatments into the clinic as quickly as possible.

According to MyMD Chief Scientific Officer Adam Kaplin, M.D., Ph.D., “The importance of our upcoming Phase 2 trial can’t be overstated. Despite the prevalence of COVID-19-related mental illness, our trial will be the first clinical trial to date of a pharmaceutical intervention to treat COVID-19-related immune-mediated depression.”

Aging and Lifespan

As an immuno-metabolic regulator, MYMD-1 is being developed to target aging (such as sarcopenia and frailty) and depression in age or inflammatory-related diseases. It also shows potential as an anti-fibrotic and anti-prolific therapeutic.

“We are equally excited to launch a second Phase 2 trial of MYMD-1 in the near term,” Dr. Chapman added. “With two Phase 2 trials in progress simultaneously, we are working to position ourselves to be able to commercialize and monetize two assets with very promising combined market value.”

About MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD) is a clinical stage pharmaceutical company committed to extending healthy lifespan in humans by focusing on developing two therapeutic platforms. MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immunometabolic system to control TNF-α and other pro-inflammatory cytokines. MYMD-1 is being developed to treat autoimmune diseases, including those currently treated with non-selective TNF-α blocking drugs, and aging and longevity. The Company’s second drug platform, Supera-CBD, is based on a novel synthetic derivative of cannabidiol (CBD) that targets numerous key receptors including CB2 and opioid receptors and inhibits monoamine oxidase. Supera-CBD is being developed to address the rapidly growing CBD market, that includes FDA approved drugs and CBD products not currently regulated as a drug. For more information, visit www.mymd.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release may contain forward-looking statements. These forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any expected future results, performance, or achievements. Forward-looking statements speak only as of the date they are made and none of MyMD nor its affiliates assume any duty to update forward-looking statements. Words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “may,” “plan,” “will,” “would” and other similar expressions are intended to identify these forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, without limitation: the timing of, and MyMD’s ability to, obtain and maintain regulatory approvals for clinical trials of MyMD’s pharmaceutical candidates; the timing and results of MyMD’s planned clinical trials for its pharmaceutical candidates; the amount of funds MyMD requires for its pharmaceutical candidates; increased levels of competition; changes in political, economic or regulatory conditions generally and in the markets in which MyMD operates; MyMD’s ability to retain and attract senior management and other key employees; MyMD’s ability to quickly and effectively respond to new technological developments; MyMD’s ability to protect its trade secrets or other proprietary rights, operate without infringing upon the proprietary rights of others and prevent others from infringing on MyMD’s proprietary rights; and the impact of the ongoing COVID-19 pandemic on MyMD’s results of operations, business plan and the global economy. A discussion of these and other factors with respect to MyMD is set forth in the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2021, filed by MyMD on May 18, 2021. Forward-looking statements speak only as of the date they are made and MyMD disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise.

__________________________

1National Center for Biological Information

Investor Contact:

Robert Schatz

(646) 421-9523

[email protected]

www.mymd.com

Media Contact:

Will Johnson

201-465-8019

[email protected]

www.antennagroup.com

KEYWORDS: United States North America Maryland

INDUSTRY KEYWORDS: Stem Cells Biotechnology Health General Health Pharmaceutical Mental Health Other Science Research Infectious Diseases Science Clinical Trials

MEDIA:

Astronics and 3Oe Scientific’s Iggy™ Device Wins America by Design: People’s Choice Award

Astronics and 3Oe Scientific’s Iggy™ Device Wins America by Design: People’s Choice Award

Nationally broadcast TV series showcases innovation, ingenuity and design excellence

EAST AURORA, N.Y.–(BUSINESS WIRE)–
Astronics Corporation (Nasdaq: ATRO), a leading provider of advanced technologies for global aerospace, defense, and other mission critical industries, and 3Oe Scientific Inc., a science technology company leveraging aqueous ozone to eradicate harmful pathogens, announced that the Iggy™ hand rinsing device has been declared winner of America by Design: People’s Choice Award. 3Oe Scientific partnered with PDT, an Astronics Company, to design and manufacture Iggy™ in response to the Covid-19 pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210805005656/en/

Iggy™ uses aqueous ozone, known to kill coronavirus in seconds, and is being installed in schools across the country. (Photo: Business Wire)

Iggy™ uses aqueous ozone, known to kill coronavirus in seconds, and is being installed in schools across the country. (Photo: Business Wire)

The design project, “3Oe & PDT: Saving Lives With Engineered Water,” was selected from nearly 30 featured innovations in Season 1 of the nationally broadcast “America by Design” television series showcased in Episode 4. The series features every type of innovation, from personal devices to transportation and medical advancements, uncovering the key ingredients of impactful design. Chosen by the viewers, Iggy™ edged out the top 10 finalists to be voted America’s favorite innovation to win the People’s Choice Award.

Iggy™ uses 3Oe Scientific’s proprietary technology to produce an intense spray fortified with aqueous ozone that does not cause skin irritation. When used as part of an overall approach to health and wellbeing, Iggy™ enhances the effectiveness of hand hygiene programs that reduce the risk of transmission of infectious microbes.

Astronics is the exclusive manufacturer of Iggy™, paving the way to meet the growing demand for aqueous ozone technology and harness the power of nature’s chemical-free disinfectant. Iggy™ was designed to simplify and improve the traditional 20-second hand rinsing process with its user-centered design approach. PDT and 3Oe Scientific developed Iggy™ after extensive research, design, engineering and prototype iterations. The connected device ensures a frictionless, touch-free experience with complete spray coverage, eliminating hand-rubbing.

“We are honored to be chosen by the viewers of America by Design,” said Mark Schwartz, Vice President of PDT. “The program featured so many great innovations and we are proud to see that the significant design work behind Iggy™ was recognized among them.”

Dr. Thomas Foust, Founder and CEO of 3Oe Scientific, said, “We’re excited for the recognition this incredible award brings to aqueous ozone technology. Our goal is to create healthier communities, and this helps raise awareness as Iggy™ continues to be installed in schools, businesses and public areas across America.”

About Astronics Corporation

Astronics Corporation (Nasdaq: ATRO) serves the world’s aerospace, defense, and other mission critical industries with proven, innovative technology solutions. Astronics works side-by-side with customers, integrating its array of power, connectivity, lighting, structures, interiors and test technologies to solve complex challenges. For over 50 years, Astronics has delivered creative, customer-focused solutions with exceptional responsiveness. Today, global airframe manufacturers, airlines, militaries, completion centers and Fortune 500 companies rely on the collaborative spirit and innovation of Astronics. The Company’s strategy is to increase its value by developing technologies and capabilities that provide innovative solutions to its targeted markets.

For more information on Astronics and its solutions, visit Astronics.com.

About 3Oe Scientific, Inc.

3Oe Scientific Inc. is a disruptive technology company dedicated to leveraging the oxidizing power of aqueous ozone to eradicate harmful pathogens safely across multiple clinical and commercial settings. 3Oe Scientific works with clients such as the Mayo Clinic, Cobb County Schools, Hancock Medical System and a renowned team of medical and technical advisors as it deploys its proprietary, award-winning Iggy™ device in schools, businesses and public spaces.

For more information, visit www.3Oescientific.com.

Company Contact

PDT, an Astronics Company

Nick Cucci

Business Development

[email protected]

+1.847.821.3000 x 759

Media Relations

Astronics Corporation

[email protected]

Company Contact

3Oe Scientific Inc.

Susana Duarte de Suarez

Public Relations

[email protected]

+1.617.633.8927

 

 

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: General Health Hardware Technology Medical Devices Infectious Diseases Other Manufacturing Science Engineering Medical Supplies Other Technology Health Other Science Manufacturing

MEDIA:

Photo
Photo
Iggy™ uses aqueous ozone, known to kill coronavirus in seconds, and is being installed in schools across the country. (Photo: Business Wire)
Logo
Logo

ESS Inc. to Present at Upcoming Investor Conferences

WILSONVILLE, Ore., Aug. 05, 2021 (GLOBE NEWSWIRE) — ESS Tech, Inc. (“ESS Inc.”, “ESS” or the “Company”), a manufacturer of long-duration iron flow batteries for commercial and utility-scale energy storage applications, today announced that Eric Dresselhuys, chief executive officer, will present virtually at the following two conferences:

  • The 10th Annual Needham Industrial Tech, Robotics, & Clean Tech 1×1 Conference on Monday, August 9 at 8:00 a.m. PT.  
  • The Canaccord Genuity 41st Annual Growth Conference on Wednesday, August 11 at 10:00 a.m. PT.

A link to the live webcast of Mr. Dresselhuys’ presentations will be available on the ESS website at www.essinc.com/investors. A recording and transcript of the presentations will be posted following the events in the same location.


About ESS Inc.


ESS Inc. designs, builds and deploys environmentally sustainable, low-cost, iron flow batteries for long-duration commercial and utility-scale energy storage applications requiring from 4 to 12 hours of flexible energy capacity. The Energy Warehouse™ and Energy Center™ use earth-abundant iron, salt, and water for the electrolyte, resulting in an environmentally benign, long-life energy storage solution for the world’s renewable energy infrastructure. Established in 2011, ESS Inc. enables project developers, utilities, and commercial and industrial facility owners to make the transition to more flexible non-lithium-ion storage that is better suited for the grid and the environment. For more information visit www.essinc.com.

ESS recently announced it would become a public company through a merger with a special purpose acquisition company, ACON S2 Acquisition Corp. (NASDAQ: STWO). Closing of the merger is subject to approval by the shareholders of both ESS and ACON S2 Acquisition Corp. and the satisfaction or waiver of certain other conditions.

Additional Information and Where to Find It

This communication is being made in respect of the proposed transaction involving ESS and ACON S2 Acquisition Corp. (“ACON S2”). A full description of the terms of the transaction is provided in the registration statement on Form S4 (File No. 333-257232) filed with the SEC by ACON S2 that includes a prospectus with respect to the combined company’s securities to be issued in connection with the business combination and a proxy statement with respect to the shareholder meeting of ACON S2 to vote on the business combination. ACON S2 urges its investors, shareholders and other interested persons to read, when available, the preliminary proxy statement/prospectus as well as other documents filed with the SEC because these documents will contain important information about ACON S2, ESS and the transaction. After the registration statement is declared effective, the definitive proxy statement/prospectus to be included in the registration statement will be mailed to shareholders of ACON S2 as of a record date to be established for voting on the proposed business combination. Once available, shareholders will also be able to obtain a copy of the S4, including the proxy statement/prospectus, and other documents filed with the SEC without charge, by directing a request to: ACON S2, 1133 Connecticut Avenue NW Suite 700, Washington, DC 20036. The preliminary and definitive proxy statement/prospectus to be included in the registration statement, once available, can also be obtained, without charge, at the SEC’s website (www.sec.gov).

Participants in the Solicitation

ACON S2 and ESS and their respective directors and officers may be deemed to be participants in the solicitation of proxies from ACON S2’s stockholders in connection with the proposed transaction. Information about ACON S2’s directors and executive officers and their ownership of ACON S2’s securities is set forth in ACON S2’s filings with the SEC. To the extent that holdings of ACON S2’s securities have changed since the amounts printed in ACON S2’s Registration Statement on Form S-1, such changes have been or will be reflected on Statements of Change in Ownership on Form 4 filed with the SEC. Additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction may be obtained by reading the proxy statement/consent solicitation statement/prospectus regarding the proposed transaction when it becomes available. You may obtain free copies of these documents as described in the preceding paragraph.

No Offer or Solicitation

This communication is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the potential transaction and shall not constitute an offer to sell or a solicitation of an offer to buy the securities of ACON S2, ESS or the combined company, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act.

Forward-Looking Statements

This communication contains certain forward-looking statements, including statements regarding ACON S2’s, ESS’ or their management teams’ expectations, hopes, beliefs, intentions or strategies regarding the future. The words “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intends”, “may”, “might”, “plan”, “possible”, “potential”, “predict”, “project”, “should”, “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements are based on ACON S2’s and ESS’ current expectations and beliefs concerning future developments and their potential effects on ACON S2, ESS or any successor entity of the proposed transactions. Many factors could cause actual future events to differ materially from the forward-looking statements in this presentation, including but not limited to: (i) the risk that the proposed transactions may not be completed in a timely manner or at all, which may adversely affect the price of ACON S2’s securities, (ii) the failure to satisfy the conditions to the consummation of the proposed transactions, (iii) the occurrence of any event, change or other circumstance that could give rise to the termination of the business combination, (iv) the effect of the announcement or pendency of the proposed transactions on ESS’ business relationships, operating results and business generally, (v) risks that the proposed transactions disrupt current plans and normal operations of ESS, (vi) changes in the competitive and highly regulated industries in which ESS plans to operate, variations in operating performance across competitors, changes in laws and regulations affecting ESS’ business and changes in the combined capital structure and (vii) the ability to implement business plans, forecasts and other expectations after the completion of the proposed transactions, and identify and realize additional opportunities. There can be no assurance that the future developments affecting ACON S2, ESS or any successor entity of the proposed transactions will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond ACON S2’s or ESS’ control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of ACON S2’s registration statement on Form S-1 (File No. 333-248515), the registration statement on Form S4 (File No. 333-257232) filed in connection with the business combination, and other documents filed by ACON S2 from time to time with the SEC. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Except as required by law, ACON S2 and ESS are not undertaking any obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise. Neither ACON S2 nor ESS gives any assurance that either the ACON S2 or ESS, or the combined company, will achieve its expectations.


Contacts


Investors:
Erik Bylin
[email protected]

Media:
Gene Hunt
Trevi Communications, Inc.
978.750.0333 x.101
[email protected]



Moody’s Analytics Earns #2 Overall Ranking in Chartis Research STORM50

Moody’s Analytics Earns #2 Overall Ranking in Chartis Research STORM50

NEW YORK–(BUSINESS WIRE)–
Moody’s Analytics is #2 in the inaugural Chartis Research STORM50 (Statistical Techniques, Optimization frameworks and Risk Models) ranking of the world’s leading providers of quantitative solutions for the financial industry.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210805005744/en/

Chartis’ STORM50 ranking measures the strength of solutions in quantitative modeling and software, assessing the level of innovation and the quality of the underlying computational infrastructure. The scoring is based on five criteria: breadth and coverage, impact, computational infrastructure, innovation, and strategy.

In addition to the #2 ranking overall, Moody’s Analytics placed first in 14 of 55 categories, including Breadth & Coverage, Impact, Strategy, and Innovation, evidencing the depth of the company’s modeling expertise.

“The inaugural Chartis Research STORM50 ranking highlights our ability to deliver an integrated view of risk through robust and innovative solutions,” said Nick Reed, Chief Product Officer at Moody’s Analytics. “I’m glad to see recognition of our ability to help our customers make better decisions amid uncertainty by quantifying the impact of possible future scenarios.”

Financial models are becoming more common in key areas of finance. As a result, market participants require more advanced techniques, such as artificial intelligence (AI) and natural language processing (NLP). Moody’s Analytics develops solutions that help its customers measure and understand a range of risks. The company offers extensive datasets, robust analytical tools, and advanced software to help them spotlight risks more clearly and identify opportunities for sustainable growth.

“The Moody’s Analytics position in the STORM50 rankings is a testament to the company’s overall strength in quantitative technologies and software solutions for financial markets,” said Sid Dash, Research Director at Chartis Research. “The award for breadth and coverage, in particular, recognizes that Moody’s Analytics offers analytics across many risk categories (including credit, ALM, securitization and regulatory reporting) for numerous business sectors, including banking, insurance, and the buy-side.”

This latest win adds to the growing list of industry recognition for Moody’s Analytics.

Moody’s Analytics, Moody’s, and all other names, logos, and icons identifying Moody’s Analytics and/or its products and services are trademarks of Moody’s Analytics, Inc. or its affiliates. Third-party trademarks referenced herein are the property of their respective owners.

About Moody’s Analytics

Moody’s Analytics provides financial intelligence and analytical tools to help business leaders make better, faster decisions. Our deep risk expertise, expansive information resources, and innovative application of technology help our clients confidently navigate an evolving marketplace. We are known for our industry-leading and award-winning solutions, made up of research, data, software, and professional services, assembled to deliver a seamless customer experience. We create confidence in thousands of organizations worldwide, with our commitment to excellence, open mindset approach, and focus on meeting customer needs. For more information about Moody’s Analytics, visit our website or connect with us on Twitter and LinkedIn.

Moody’s Analytics, Inc. is a subsidiary of Moody’s Corporation (NYSE: MCO). Moody’s Corporation reported revenue of $5.4 billion in 2020, employs approximately 11,500 people worldwide, and maintains a presence in more than 40 countries.

TRACY FINE

Moody’s Analytics Communications

+1.415.874.6013

Moody’s Analytics Media Relations

moodysanalytics.com

twitter.com/moodysanalytics

linkedin.com/company/moodysanalytics

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Software Insurance Finance Consulting Banking Data Management Professional Services Technology

MEDIA:

Logo
Logo
Logo
Logo

WRAP Reports Hillsborough Sheriff Department Purchases BolaWrap® Devices Following Successful Pilot Program

Department also releases bodycam field use videos

TEMPE, Ariz., Aug. 05, 2021 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (the “Company” or “WRAP”) (Nasdaq: WRAP), a global leader in innovative public safety technologies and services, reports on Florida’s Hillsborough County Sheriff’s Office (HCSO) announcement yesterday that it will be strategically deploying 165 BolaWrap Remote Restraint Devices following a successful pilot program earlier this year. In addition, HCSO released bodycam footage from three different uses during the trial period highlighting the BolaWrap as an effective and quick method for de-escalation in crisis situations.

“We are pleased that Hillsborough County Sheriff’s Office will be implementing BolaWraps following a successful pilot program with 20 deputies that commenced earlier this year,” said Tom Smith, CEO and President of WRAP. “The bodycam use case videos released yesterday by Hillsborough Sheriff’s Office demonstrate successful outcomes of early use of BolaWrap to prevent escalation to higher, pain compliance uses of force. We are extremely proud to see our products gaining traction and confidence from the law enforcement community, which will assist in improving crisis situation procedures and the overall relationship with the communities they serve.”

Hillsborough Sheriff Chad Chronister commented during a press conference yesterday, “I am pleased to announce that we are expanding our de-escalation capabilities with the addition of a new restraint device – the BolaWrap. The BolaWrap is a less-lethal tool that may be used to restrain a noncompliant individual.” He added, “With such positive results and our continued pursuit of de-escalation training techniques and resources, we will be strategically deploying 165 BolaWraps throughout the sheriff’s office in the coming weeks, to include members of our Uniform Patrol Districts and our Behavioral Resource Unit.”

“The BolaWrap helps build confidence within the community that they can have safer interactions with law enforcement, and it helps law enforcement by letting them know that a gun doesn’t have to be the only option,” said Yvette Lewis, President of the NAACP Hillsborough County Branch.

About WRAP
WRAP Technologies (Nasdaq: WRAP) is a global leader in innovative public safety technologies and services. WRAP develops creative solutions to complex issues and empowers public safety officials to protect and serve their communities through its portfolio of advanced technology and training solutions. 

WRAP’s BolaWrap® Remote Restraint device is a patented, hand-held pre-escalation and apprehension tool that discharges a Kevlar® tether to temporarily restrain uncooperative suspects and persons in crisis from a distance. Through its many field uses and growing adoption by agencies across the globe, BolaWrap is proving to be an effective tool to help law enforcement safely detain persons without injury or the need to use higher levels of force.

Wrap Reality, the Company’s virtual reality training system, is a fully immersive training simulator and comprehensive public safety training platform providing first responders with the discipline and practice in methods of de-escalation, conflict resolution, and use-of-force to better perform in the field.

WRAP’s headquarters are in Tempe, Arizona. For more information, please visit wrap.com.

Follow WRAP here:
WRAP on Facebook: https://www.facebook.com/wraptechnologies/
WRAP on Twitter: https://twitter.com/wraptechinc
WRAP on LinkedIn: https://www.linkedin.com/company/wraptechnologies/

Trademark Information
BolaWrap, Wrap and Wrap Reality are trademarks of Wrap Technologies, Inc. All other trade names used herein are either trademarks or registered trademarks of the respective holders.

Cautionary Note on Forward-Looking Statements – Safe Harbor Statement
This press release contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to: statements regarding the Company’s overall business; total addressable market; and, expectations regarding future sales and expenses. Words such as “expect”, “anticipate”, “should”, “believe”, “target”, “project”, “goals”, “estimate”, “potential”, “predict”, “may”, “will”, “could”, “intend”, and variations of these terms or the negative of these terms and similar expressions are intended to identify these forward-looking statements. Moreover, forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond the Company’s control. The Company’s actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including but not limited to: the Company’s ability to successfully implement training programs for the use of its products; the Company’s ability to manufacture and produce product for its customers; the Company’s ability to develop sales for its new product solution; the acceptance of existing and future products; the availability of funding to continue to finance operations; the complexity, expense and time associated with sales to law enforcement and government entities; the lengthy evaluation and sales cycle for the Company’s product solution; product defects; litigation risks from alleged product-related injuries; risks of government regulations; the business impact of health crises or outbreaks of disease, such as epidemics or pandemics; the ability to obtain export licenses for countries outside of the US; the ability to obtain patents and defend IP against competitors; the impact of competitive products and solutions; and the Company’s ability to maintain and enhance its brand, as well as other risk factors mentioned in the Company’s most recent annual report on Form 10-K, quarterly report on Form 10-Q, and other SEC filings. These forward-looking statements are made as of the date of this press release and were based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Except as required by law, the Company undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.

Contact:

Paul M. Manley
VP – Investor Relations
(612) 834-1804
[email protected]

Media Contact: [email protected]



Adial Pharmaceuticals Announces Closing of $5 Million Private Placement Priced at a Premium to Market

Financing fully funds ONWARD™ Phase 3 trial until data read-out

CHARLOTTESVILLE, Va., Aug. 05, 2021 (GLOBE NEWSWIRE) — Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced that it has completed the $5,000,002 private placement of 1,666,668 shares of common stock at a price of $3.00 per share (the “Shares”) on August 4, 2021. The private placement was led by Bespoke Growth Partners, Inc., which invested $2,500,000, and is a company controlled by Mark Peikin, Adial’s Chief Strategy Officer, and also included Richard Gilliam, founder of Cumberland Resources, and Keystone Capital Partners LLC, all of whom were previous investors in the Company. No warrants were issued in this financing, and Brookline Capital Markets, a division of Arcadia Securities, LLC, acted as an advisor on the transaction.

As previously disclosed, the Company received $500,002 upon the parties’ execution of their respective Securities Purchase Agreements and has now received the balance of $4,500,000 following the U.S. Securities and Exchange Commission declaring the registration statement on Form S-3, registering the resale of the private placement shares, effective on July 29, 2021.

In combination with the private placement previously announced on June 3, 2021, this transaction marks the completion of a set of financings totaling $7.1 million.

William Stilley, Adial’s Chief Executive Officer, commented, “We are pleased to close this last piece of our $7.1 million in private placements, and we appreciate the support of the participating investors. We believe this latest financing illustrates the tremendous confidence and support of our existing shareholders, as well as our conviction in the positive outlook for the business. This funding is anticipated to provide us more than sufficient capital to complete the ONWARD™ Phase 3 trial of AD04 as a genetically targeted treatment for Alcohol Use Disorder through data read-out. Additionally, it is expected to allow us to achieve key milestones for our pre-clinical adenosine program for non-opiate pain relief.”

About Adial Pharmaceuticals, Inc.

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of treatments for addictions. The Company’s lead investigational new drug product, AD04, is a genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) and is currently being investigated in the Company’s landmark ONWARD™ pivotal Phase 3 clinical trial for the potential treatment of AUD in subjects with certain target genotypes, which are to be identified using the Company’s proprietary companion diagnostic genetic test. A Phase 2b clinical trial of AD04 for the treatment of AUD showed promising results in reducing frequency of drinking, quantity of drinking and heavy drinking (all with statistical significance), and no overt safety concerns (there were no statistically significant serious adverse events reported). AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity. The Company is also developing adenosine analogs for the treatment of pain and other disorders. Additional information is available at www.adialpharma.com.

About the Landmark ONWARD™ Pivotal Phase 3 Clinical Trial

The ONWARD trial is a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel group, Phase 3 clinical study to evaluate the efficacy, safety and tolerability of AD04 in patients with Alcohol Use Disorder (AUD) and selected polymorphisms in the serotonin transporter and receptor genes. Patients are genetically screened prior to enrollment in the ONWARD trial so that only genetically positive patients are enrolled. The primary endpoint for analysis of efficacy is the change from baseline in the monthly number of heavy drinking days during the last 8 weeks of the 24-week treatment period. ONWARD is currently being conducted in 25 clinical sites in seven countries in Scandinavia and Central and Eastern Europe (Sweden, Finland, Poland, Latvia, Estonia, Bulgaria and Croatia). The principal investigator is Professor Hannu E.R. Alho, Emeritus Professor of Addiction Medicine at the University of Helsinki.

Forward Looking Statements

This communication contains certain “forward-looking statements” within the meaning of the U.S. federal securities laws. Such statements are based upon various facts and derived utilizing numerous important assumptions and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could” are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. The forward-looking statements include statements regarding
the financing illustrating the tremendous confidence and support of our existing shareholders, as well as our conviction in the positive outlook for the business, the funding providing us more than sufficient capital to complete the ONWARD™ Phase 3 trial of AD04 as a genetically targeted treatment for Alcohol Use Disorder through data read-out, this funding allowing us to achieve key milestones for our pre-clinical adenosine program for non-opiate pain relief and the potential of AD04 to treat other addictive disorders such as opioid use disorder, gambling, and obesity. Any forward-looking statements included herein reflect our current views, and they involve certain risks and uncertainties, including, among others, our ability to maintain the confidence and support of our existing shareholders, as well as our conviction in the positive outlook for the business, our ability to complete the ONWARD™ Phase 3 trial of AD04 as a genetically targeted treatment for Alcohol Use Disorder through data read-out as planned, our ability to achieve key milestones for our pre-clinical adenosine program for non-opiate pain relief, our ability to enroll patients within the timelines anticipated and complete clinical trials on time and achieve desired results and benefits as expected, our ability to obtain regulatory approvals for commercialization of product candidates or to comply with ongoing regulatory requirements, regulatory limitations relating to our ability to promote or commercialize our product candidates for specific indications, acceptance of its product candidates in the marketplace and the successful development, marketing or sale of products, our ability to maintain our license agreements, the continued maintenance and growth of our patent estate, our ability to establish and maintain collaborations, our ability to obtain or maintain the capital or grants necessary to fund its research and development activities, and our ability to retain our key employees or maintain our Nasdaq listing. These risks should not be construed as exhaustive and should be read together with the other cautionary statement included in our Annual Report on Form 10-K for the year ended December 31, 2020, subsequent Quarterly Reports on Form 10-Q and current reports on Form 8-K filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it was initially made. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise, unless required by law.

Contact:

Crescendo Communications, LLC                        
David Waldman / Natalya Rudman                        
Tel: 212-671-1021                                
Email: [email protected]

 



WOW! Reports Second Quarter 2021 Results

Record High-Speed Data Revenue of $156.4 million, up 14% compared to the second quarter of 2020

PR Newswire

ENGLEWOOD, Colo., Aug. 5, 2021 /PRNewswire/ — WideOpenWest, Inc. (“WOW!” or the “Company”) (NYSE: WOW), one of the nation’s leading broadband providers, with an efficient, high-performing network that passes more than three million residential, business and wholesale consumers, today announced financial and operating results for the second quarter ended June 30, 2021.


Second Quarter 2021 Highlights


 (1)(2)

  • Total Revenue of $287.3 million; Net Income of $12.4 million; Diluted Earnings Per Share of $0.15
  • HSD Revenue totaled $156.4 million, an increase of $19.1 million, or 14%, compared to second quarter of 2020
  • Adjusted EBITDA was $117.8 million, an increase of $16.5 million, or 16%, compared to the second quarter of 2020
  • Adjusted EBITDA margin of 41.0% compared to 35.9% for the quarter ended June 30, 2020
  • Free Cash Flow totaled $23.1 million
  • Added 3,400 HSD RGUs
  • Announced two transactions to sell five service areas for a combined $1.8 billion


Year-to-Date 2021 Highlights

 (1)(2)

  • Total Revenue of $573.6 million; Net Income of $22.0 million; Diluted Earnings Per Share of $0.27
  • HSD Revenue totaled $309.1 million, an increase of $35.2 million, or 13%, compared to the corresponding period of 2020
  • Adjusted EBITDA was $230.2 million, an increase of $29.8 million, or 15%, compared to the corresponding period of 2020
  • Adjusted EBITDA margin of 40.1% compared to 35.4% for the six months ended June 30, 2020
  • Free Cash Flow totaled $41.4 million
  • Added 13,400 HSD RGUs

(1)


Refer to “Non-GAAP Financial Measures” “Unaudited Reconciliations of GAAP Measures to Non-GAAP Measures, “and Subscriber Information” in this Press Release for definitions and information related to Adjusted EBITDA, Free Cash Flow and reconciliation of non-GAAP measures to the closest comparable GAAP measures and why our management thinks it is beneficial to present such non-GAAP measures.

(2)


On June 30, 2021, the Company announced the pending sale of certain assets together with certain liabilities of five service areas. For presentation purposes related to this announcement, the related assets, liabilities and financial results of these five service areas were classified as discontinued operations. Refer to tables that follow for the reconciliation of continuing and discontinued operations.

“Our broadband-first strategy continues to drive our business forward with another record quarter of high-speed data revenue, strong Adjusted EBITDA and EBITDA margins, all up significantly from the same period last year,” said Teresa Elder, WOW!’s CEO. “In addition to our strong results, the recently announced agreements to sell five service areas in two separate transactions for a combined $1.8 billion, reflects the attractiveness of our assets and enhances our overall financial strength and flexibility.”

“We continue to deliver excellent high-speed data revenue and Adjusted EBITDA growth as we maintain an aggressive focus on execution and delivering returns to shareholders,” said John Rego, WOW!’s CFO. “An Adjusted EBITDA margin of 41%, free cash flow in the quarter above $23 million and a leverage ratio of 4.8x, all demonstrate the strength of our business and broadband-first strategy.”


Revenue

Total Revenue was $287.3 million for the quarter ended June 30, 2021, up $5.3 million, or 2%, as compared to the corresponding period in 2020.

Total Subscription Revenue for the quarter ended June 30, 2021 was $269.4 million, up $5.5 million, or 2%, as compared to the corresponding period in 2020. The increase was driven by an increase in average revenue per unit (“ARPU”) as HSD customers upgrade to higher speed offerings coupled with an increase in volume attributable exclusively to the addition of HSD Subscribers. These increases were partially offset by a shift in service offering mix, as the Company continues to experience a reduction in Video and Telephony RGUs.

Other Business Services Revenue totaled $6.1 million for the quarter ended June 30, 2021, down $0.3 million as compared to the corresponding period in 2020. The decrease is primarily due to a decrease in data center revenue.

Other Revenue totaled $11.8 million for the quarter ended June 30, 2021, up $0.1 million as compared to the corresponding period in 2020, primarily due to increases in advertising revenue.


Costs and Expenses

Operating Expenses (excluding Depreciation and Amortization) totaled $132.7 million for the quarter ended June 30, 2021, down $13.1 million, or 9%, compared to the corresponding period in 2020 primarily due to lower direct expenses, specifically programming expense, which aligns with the reduction in Video RGUs between periods. Selling, General, and Administrative expenses totaled $48.3 million for the quarter ended June 30, 2021, up $4.4 million, or 10%, compared to the corresponding period in 2020, primarily due to increases in marketing, stock compensation, professional service and legal expenses.   


Net Income and Earnings Per Share

Net Income for the quarter ended June 30, 2021 was $12.4 million, compared to $2.2 million for the quarter ended June 30, 2020. Diluted Earnings Per Share for the quarter ended June 30, 2021 was $0.15, compared to Diluted Earnings Per Share of $0.03 for the quarter ended June 30, 2020.


Adjusted EBITDA

Adjusted EBITDA for the quarter ended June 30, 2021 was $117.8 million, an increase of $16.5 million, compared to the corresponding period in 2020. Adjusted EBITDA margin was 41.0% for the quarter ended June 30, 2021, as compared to 35.9% for the quarter ended June 30, 2020.


Subscribers

WOW! reported Total Subscribers of 857,400 as of June 30, 2021, an increase of 12,900, or 2%, compared to June 30, 2020, up 2,700 compared to March 31, 2021. HSD RGUs totaled 826,300 as of June 30, 2021, an increase of 20,700, or 3%, compared to June 30, 2020, up 3,400 compared to March 31 2021.


E


dge-Outs

Edge-Out Projects reached a total of 196,100 homes passed and 49,500 Subscribers since inception.

The 2019 Edge-Out projects include 8,800 Subscribers, which represents 17.9% penetration on such nodes. The 2020 Edge-Out projects include 1,200 Subscribers, which represents 19.5% penetration on such nodes. 


Capital Expenditures

Capital Expenditures totaled $56.2 million for the quarter ended June 30, 2021, representing a $1.0 million decrease compared to the quarter ended June 30, 2020. The decrease is primarily related to decreased expenditures related to customer premise equipment (“CPE”), partially offset by increases in network enhancements focused on increasing bandwidth capacity, standardization and reliability to meet the needs of our customers. Capital Expenditures for the quarter ended June 30, 2021 equates to 20% of Total Revenue for the quarter ended June 30, 2021.


Liquidity and Leverage

As of June 30, 2021, the total outstanding amount of long-term debt and finance lease obligations was $2.2 billion, and cash and cash equivalents were $23.3 million. Total Net Leverage as of June 30, 2021, was 4.80X on a LTM Adjusted EBITDA basis, down from 5.01X at March 31, 2021, and undrawn revolver capacity totaled $261.7 million. Free Cash Flow was $23.1 million for the quarter ended June 30, 2021.


Webcast

WOW! will host a webcast on Thursday, August 5, 2021, at 8:00 a.m. Eastern to discuss the financial and operating results contained in this press release. The conference call and webcast will be broadcast live on the Company’s investor relations website at ir.wowway.com. Those parties interested in participating can use the information as follows:

Call Date:

Thursday, August 5, 2021

Call Time:

8:00 a.m. Eastern

Dial In:

(833) 312-1362

International:

(236) 714-2635

Conf. ID:

5185156

A replay of the call will be available on August 5, 2021, at 11:00 a.m. ET, on the investor relations website or by telephone. To access the telephone replay, which will be available until September 3, 2021, at 11:59 p.m. ET, please dial (800) 585-8367 or (416) 621-4642 and use conference ID 5185156.


WIDEOPENWEST, INC. AND SUBSIDIARIES


CONSOLIDATED BALANCE SHEETS


(unaudited)



June 30,
2021


December 31,
2020


(in millions, except share data)

Assets

Current assets

Cash and cash equivalents

$

23.3

$

12.4

Accounts receivable—trade, net of allowance for doubtful accounts of $5.2 and $6.7, respectively

38.3

44.4

Accounts receivable—other, net

2.4

2.8

Prepaid expenses and other

35.1

25.0

Current assets held for sale

29.9

30.2

Total current assets

129.0

114.8

Right-of-use lease assets—operating

20.3

22.1

Property, plant and equipment, net

718.6

720.9

Franchise operating rights

620.1

620.1

Goodwill

225.1

225.1

Intangible assets subject to amortization, net

1.8

1.9

Other non-current assets

42.3

42.1

Non-current assets held for sale

730.1

740.0

Total assets

$

2,487.3

$

2,487.0

Liabilities and stockholders’ deficit

Current liabilities

Accounts payable—trade

$

29.8

$

32.4

Accrued interest

3.8

4.0

Current portion of long-term lease liability—operating

6.0

5.8

Accrued liabilities and other

70.7

79.7

Current portion of long-term debt and finance lease obligations

70.9

37.5

Current portion of unearned service revenue

30.0

28.6

Current liabilities held for sale

46.9

47.9

Total current liabilities

258.1

235.9

Long-term debt and finance lease obligations—less current portion and debt issuance costs

2,176.8

2,228.5

Long-term lease liability—operating

16.3

19.0

Deferred income taxes, net

205.0

200.6

Other non-current liabilities

12.9

13.1

Non-current liabilities held for sale

2.4

2.3

Total liabilities

2,671.5

2,699.4

Commitments and contingencies

Stockholders’ deficit:

Preferred stock, $0.01 par value, 100,000,000 shares authorized; 0 shares issued and outstanding

Common stock, $0.01 par value, 700,000,000 shares authorized; 95,888,217 and 95,187,161 issued as
of June 30, 2021 and December 31, 2020, respectively; 87,111,194 and 86,847,797 outstanding as of
June 30, 2021 and December 31, 2020, respectively

1.0

1.0

Additional paid-in capital

340.9

333.8

Accumulated other comprehensive income (loss)

(6.5)

Accumulated deficit

(438.0)

(460.0)

Treasury stock at cost, 8,777,023 and 8,339,364 shares as of June 30, 2021 and December 31, 2020,
respectively

(88.1)

(80.7)

Total stockholders’ deficit

(184.2)

(212.4)

Total liabilities and stockholders’ deficit

$

2,487.3

$

2,487.0

 


WIDEOPENWEST, INC. AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE MONTHS ENDED


(unaudited)



Three months ended
June 30, 2021



Three months ended
June 30, 2020


Continued


Discontinued


Total


Continued


Discontinued


Total


(in millions, except per share data)

Revenue:

HSD

$

98.7

$

57.7

$

156.4

$

86.9

$

50.4

$

137.3

Video

55.3

36.4

91.7

61.9

40.6

102.5

Telephony

14.6

6.7

21.3

16.9

7.2

24.1

Total subscription services revenue

168.6

100.8

269.4

165.7

98.2

263.9

Other business services

5.7

0.4

6.1

6.0

0.4

6.4

Other

7.6

4.2

11.8

7.7

4.0

11.7

Total revenue

181.9

105.4

287.3

179.4

102.6

282.0

Costs and expenses:

Operating (excluding depreciation
and amortization)

95.1

37.6

132.7

102.8

43.0

145.8

Selling, general and administrative

45.5

2.8

48.3

41.5

2.4

43.9

Depreciation and amortization

42.4

20.5

62.9

37.2

19.6

56.8

183.0

60.9

243.9

181.5

65.0

246.5

(Loss) income from operations

(1.1)

44.5

43.4

(2.1)

37.6

35.5

Other income (expense):

Interest (expense) income

(28.8)

0.4

(28.4)

(32.4)

(32.4)

(Loss) gain on sale of assets, net

(0.1)

0.2

0.1

0.4

0.4

Other income, net

0.1

0.1

0.1

0.1

(Loss) income before provision
for income taxes

(30.0)

45.2

15.2

(34.0)

37.6

3.6

Income tax benefit (expense)

7.5

(10.3)

(2.8)

7.6

(9.0)

(1.4)

Net (loss) income

$

(22.5)

$

34.9

$

12.4

$

(26.4)

$

28.6

$

2.2

(Loss) earnings per share

      Basic

$

(0.27)

$

0.42

$

0.15

$

(0.32)

$

0.35

$

0.03

      Diluted

$

(0.27)

$

0.42

$

0.15

$

(0.32)

$

0.35

$

0.03

Weighted-average common shares
outstanding

      Basic

82,828,227

81,612,359

      Diluted

82,828,227

81,612,359

 


WIDEOPENWEST, INC. AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE SIX MONTHS ENDED


(unaudited)



Six months ended
June 30, 2021


Six months ended
June 30, 2020


Continued


Discontinued


Total


Continued


Discontinued


Total


(in millions, except per share data)

Revenue:

HSD

$

195.3

$

113.8

$

309.1

$

173.3

$

100.6

$

273.9

Video

111.7

73.3

185.0

124.5

81.4

205.9

Telephony

29.6

13.5

43.1

34.1

14.6

48.7

Total subscription services revenue

336.6

200.6

537.2

331.9

196.6

528.5

Other business services

11.3

1.0

12.3

11.9

1.0

12.9

Other

15.5

8.6

24.1

16.3

8.8

25.1

Total revenue

363.4

210.2

573.6

360.1

206.4

566.5

Costs and expenses:

Operating (excluding depreciation
and amortization)

193.5

77.2

270.7

206.9

87.4

294.3

Selling, general and administrative

88.0

5.5

93.5

84.8

5.9

90.7

Depreciation and amortization

83.7

41.0

124.7

73.3

39.3

112.6

365.2

123.7

488.9

365.0

132.6

497.6

(Loss) income from operations

(1.8)

86.5

84.7

(4.9)

73.8

68.9

Other income (expense):

Interest (expense) income

(60.2)

0.4

(59.8)

(65.9)

(65.9)

(Loss) gain on sale of assets, net

(0.1)

0.2

0.1

0.6

0.1

0.7

Other income, net

0.6

0.1

0.7

0.7

0.1

0.8

(Loss) income before provision for
income taxes

(61.5)

87.2

25.7

(69.5)

74.0

4.5

Income tax benefit (expense)

16.3

(20.0)

(3.7)

15.4

(17.6)

(2.2)

Net (loss) income

$

(45.2)

$

67.2

$

22.0

$

(54.1)

$

56.4

$

2.3

(Loss) earnings per share

      Basic

$

(0.55)

$

0.82

$

0.27

$

(0.66)

$

0.69

$

0.03

      Diluted

$

(0.55)

$

0.82

$

0.27

$

(0.66)

$

0.69

$

0.03

Weighted-average common shares
outstanding

      Basic

82,433,311

81,325,795

      Diluted

82,433,311

81,325,795

 


WIDEOPENWEST, INC. AND SUBSIDIARIES


CONSOLIDATED STATEMENTS OF CASH FLOWS


(unaudited)



Six Months Ended
June 30, 


2021


2020


(in millions)

Cash flows from operating activities:

Net income

$

22.0

$

2.3

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

124.7

112.6

Deferred income taxes

2.3

0.6

Provision for doubtful accounts

5.3

12.2

Gain on sale of assets, net

(0.1)

(0.7)

Amortization of debt issuance costs and discount

2.4

2.4

Non-cash compensation

7.1

5.7

Other non-cash items

(0.1)

Changes in operating assets and liabilities:

Receivables and other operating assets

(9.3)

(11.6)

Payables and accruals

2.6

3.8

Net cash provided by operating activities

$

156.9

$

127.3

Cash flows from investing activities:

Capital expenditures

$

(115.5)

$

(115.2)

Other investing activities

0.9

(0.7)

Net cash used in investing activities

$

(114.6)

$

(115.9)

Cash flows from financing activities:

Proceeds from issuance of long-term debt

$

31.0

$

91.0

Payments on long-term debt and finance lease obligations

(55.0)

(82.8)

Purchase of shares

(7.4)

(1.0)

Net cash (used in) provided by financing activities

$

(31.4)

$

7.2

Increase (decrease) in cash and cash equivalents

10.9

18.6

Cash and cash equivalents, beginning of period

12.4

21.0

Cash and cash equivalents, end of period

$

23.3

$

39.6

Supplemental disclosures of cash flow information:

Cash paid during the periods for interest

$

59.0

$

62.6

Cash paid (received) during the periods for income taxes, net

$

1.7

$

(3.9)

Non-cash operating activities:

Operating lease additions

$

0.9

$

4.8

Non-cash financing activities:

Finance lease additions

$

3.3

$

6.6

Capital expenditure accounts payable and accruals

$

12.2

$

9.8


About WOW!

WOW! is a leading broadband services provider offering high-speed data (“HSD”), cable television (“Video”), and digital telephony (“Telephony”) services to residential and business customers.  Our vision is connecting people to their world through the WOW! experience: reliable, easy, and pleasantly surprising, every time. For more information, please visit www.wowway.com.


Cautionary Statement Regarding Forward-Looking Statements

Certain statements in this press release that are not historical facts contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  These forward-looking statements represent our goals, beliefs, plans and expectations about our prospects for the future and other future events. Forward-looking statements include all statements that are not historical fact and can be identified by terms such as “may,” “intend,” “might,” “will,” “should,” “could,” “would,” “anticipate,” “expect,” “believe,” “estimate,” “plan,” “project,” “predict,” “potential,” or the negative of these terms. Although these forward-looking statements reflect our good-faith belief and reasonable judgment based on current information, these statements are qualified by important factors, many of which are beyond our control that could cause our actual results to differ materially from those in the forward-looking statements. These factors and other risks that could cause our actual results to differ materially are set forth in the section entitled “Risk Factors” in our Annual Report filed on Form 10-K with the Securities and Exchange Commission (“SEC”) and other reports subsequently filed with the SEC. Given these uncertainties, you should not place undue reliance on any such forward-looking statements. The forward-looking statements included in this report are made as of the date hereof or the date specified herein, based on information available to us as of such date. Except as required by law, we assume no obligation to update these forward-looking statements, even if new information becomes available in the future.


Non-GAAP Financial Measures

The Company has included certain non-GAAP financial measures in this release, including Adjusted EBITDA and Free Cash Flow. These terms, as defined herein, are not intended to be considered in isolation, as a substitute for, or superior to, the financial information prepared and presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”). These terms may vary from the use of similar terms by other companies in our industry due to different methods of calculation and therefore are not necessarily comparable.

We believe that these non-GAAP measures enhance an investor’s understanding of our financial performance. We believe that these non-GAAP measures are useful financial metrics to assess our operating performance from period to period by excluding certain items that we believe are not representative of our core business. We believe that these non-GAAP measures provide investors with useful information for assessing the comparability between periods of our ability to generate cash from operations sufficient to pay taxes, to service debt and to undertake Capital Expenditures. We use these non-GAAP measures for business planning purposes and in measuring our performance relative to that of our competitors. We believe these non-GAAP measures are measures commonly used by investors to evaluate our performance and that of our competitors.

Adjusted EBITDA eliminates the impact of expenses that do not relate to overall business performance and is defined by WOW! as net income (loss) before interest expense, income taxes, depreciation and amortization (including impairments), impairment losses on intangibles and goodwill, write-off of any asset, loss on early extinguishment of debt, integration and restructuring expenses and all non–cash charges and expenses (including stock compensation expense) and certain other income and expenses. Adjusted EBITDA should not be considered as an alternative to net income (loss), operating income or any other performance measures derived in accordance with GAAP as measures of operating performance, operating cash flows or liquidity.

Free Cash Flow is defined as Net Cash Provided by Operating Activities less Capital Expenditures. Free Cash Flow presents the cash generated or used by the business in a given period.

Refer to “Reconciliations of GAAP Measures to Non-GAAP Measures” and the accompanying tables below for a reconciliation of Adjusted EBITDA to Net Income, and Net Cash Provided by Operating Activities to Free Cash Flow which are most directly comparable to their corresponding GAAP financial measure.


Subscriber Information

The Company uses the terms defined below throughout this release.

Homes passed are reported as the number of serviceable addresses, such as single residence homes, apartments and condominium units, and businesses passed by our broadband network and listed in our database.

We deliver multiple services to our customers, as such we report Total Subscribers as the number of Subscribers who receive at least one of our HSD, Video or Telephony services, without regard to which or how many services they subscribe. We define each of the individual HSD Subscribers, Video Subscribers and Telephony Subscribers as a Revenue Generating Unit (“RGU”).

While we take appropriate steps to ensure subscriber information is presented on a consistent and accurate basis at any given balance sheet date, we periodically review our policies in light of the variability we may encounter across our different markets due to the nature and pricing of products and services and billing systems. Accordingly, we may from time to time make appropriate adjustments to our subscriber information based on such reviews.


WIDEOPENWEST, INC. AND SUBSIDIARIES


Reconciliations of GAAP Measures to Non-GAAP Measures


(unaudited)

The following table provides a reconciliation of Adjusted EBITDA to Net Income for the periods presented:


 


Three months ended
June 30,


Six months ended
June 30, 


2021


2020


2021


2020


(in millions)

Net Income

$

12.4

$

2.2

$

22.0

$

2.3

Depreciation and amortization

62.9

56.8

124.7

112.6

Interest expense

28.4

32.4

59.8

65.9

Gain on sale of assets, net

(0.1)

(0.4)

(0.1)

(0.7)

Non-recurring professional fees, M&A integration and restructuring expense

7.5

6.0

13.7

13.2

Non-cash stock compensation

4.0

3.0

7.1

5.7

Other income, net

(0.1)

(0.1)

(0.7)

(0.8)

Income tax expense

2.8

1.4

3.7

2.2

Adjusted EBITDA

$

117.8

$

101.3

$

230.2

$

200.4

 

The following table provides a reconciliation of Net Cash Provided by Operating Activities to Free Cash Flow for the periods presented:


Three months ended
June 30, 


Six months ended
June 30, 


2021


2020


2021


2020


(in millions)

Net Cash Provided by Operating Activities

$

79.3

$

74.9

$

156.9

$

127.3

Less: Capital Expenditures

(56.2)

(57.2)

(115.5)

(115.2)

 Free Cash Flow

$

23.1

$

17.7

$

41.4

$

12.1

 


WIDEOPENWEST, INC. AND SUBSIDIARIES


Capital Expenditures and Subscriber Information


(unaudited)

The following table provides additional information regarding our Capital Expenditures for the periods presented:  



Three months ended
June 30, 


Six months ended
June 30, 


2021


2020


2021


2020


(in millions)

Customer premise equipment

$

25.7

$

35.6

$

56.3

$

70.4

Scalable infrastructure

12.5

7.0

24.9

12.8

Line extensions

4.9

3.6

9.8

9.2

Support capital and other

13.1

11.0

24.5

22.8

Total

$

56.2

$

57.2

$

115.5

$

115.2

Capital expenditures included in total related to:

Edge-outs

$

1.6

$

1.6

$

3.0

$

4.7

Business services

$

4.6

$

3.8

$

9.6

$

9.4

 


The following table provides an unaudited summary of our subscriber information:


June 30,
2020



September 30,
2020


December 31,
2020 (1)


March 31,
2021



June 30,
2021

Homes Passed

3,237,700

3,242,400

3,248,600

3,251,900

3,275,200

Total Subscribers

844,500

846,300

846,100

854,700

857,400

HSD RGUs

805,600

808,900

812,900

822,900

826,300

Video RGUs

351,700

328,000

306,100

288,800

272,100

Telephony RGUs

188,100

182,000

176,300

172,100

167,800

Total RGUs

1,345,400

1,318,900

1,295,300

1,283,800

1,266,200

(1)


The Company combined certain billing systems during the second quarter of 2021, which standardized the statistical reporting of key metrics. The standardized reporting led to the following decreases for subscriber and RGU counts as of December 31, 2020: total subscribers (4,500), HSD RGUs (900), Video RGUs (2,100), Telephony RGUs (700), and Total RGUs (3,700).


Additional Information Available on Website:

The information in this press release should be read in conjunction with the financial statements and footnotes contained in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, which will be posted on of our investor relations website at ir.wowway.com, when it is filed with the Securities and Exchange Commission (the “SEC”). A slide presentation to accompany the conference call and a trending schedule containing historical customer and financial data will also be available on our website.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/wow-reports-second-quarter-2021-results-301348908.html

SOURCE WideOpenWest, Inc.

Swvl To Enhance Board With Appointment Of Three Highly Accomplished Women & Tech Leaders

Victoria Grace, Lone Fønss Schrøder and Esther Dyson will bring extensive financial, technology, and automotive experience, along with deep global networks

Company leadership to reflect diversity of stakeholder base, including employees and customers

ESG principles core to Swvl’s mission of empowering underserved communities through tech-enabled mass transit solutions

PR Newswire

DUBAI, UAE, Aug. 5, 2021 /PRNewswire/ — Swvl Inc. (“Swvl” or the “Company”), a Dubai-based provider of transformative mass transit and shared mobility solutions, today announced that upon the completion of its proposed business combination with Queen’s Gambit Growth Capital (“Queen’s Gambit”) (NASDAQ: GMBT), the combined public company will appoint three highly experienced women and technology leaders to its Board of Directors:


  • Victoria Grace
    , Queen’s Gambit Founder & Chief Executive Officer;
  • Lone Fønss Schrøder, a tenured leader of innovative logistics and technology-driven companies, including Vice Chair of the Board of Directors of Volvo Cars; and

  • Esther Dyson
    , a leading angel investor focused on technology and other core sectors, with notable investments including 23andMe, Evernote, Flickr and Square.

Swvl is a mission-driven company focused on empowering underserved populations in emerging markets, particularly women, to achieve greater social and economic equity with tech-enabled mass transit solutions that are reliable, convenient, safe and affordable. With these future appointments, Swvl has made clear its commitment to ensuring the Company’s leadership reflects the same diversity as its users and growing employee base, which is currently comprised of 22 nationalities, as it continues to transform the $1 trillion global mass transit market.


Mostafa Kandil, Swvl Founder and CEO
, said, “We look forward to welcoming Victoria and Lone to our Board, along with Esther, one of our early investors. Each of these highly accomplished women will provide a unique lens, deep financial and operational experience and global networks that will be instrumental in realizing our next phase of growth. With strategic guidance from our Board, I am confident that we will create even greater value for all stakeholders moving forward.”

Mr. Kandil continued, “The reception that Swvl has received following its announced business combination with Queen’s Gambit has been truly humbling and remarkable. We look forward to updating the investment community, and all stakeholders, on the many exciting financial, operational and ESG developments underway as we continue to execute on our mission to change the paradigm of mass transit on a global scale.”

On July 28, 2021, Swvl announced a $1.5bn business combination with Queen’s Gambit. Following the closing of the transaction, which is expected to occur in the fourth calendar quarter of 2021, Swvl will become the first $1bn+ unicorn from the Middle East to list on Nasdaq and the only tech-enabled mass transit solutions company to list on any exchange. Swvl will also form an advisory committee, including two members of Queen’s Gambit, to focus on fostering continued diversity and inclusion as a public company.

About Victoria Grace

  • Trailblazing Founder and Chief Executive Officer of Queen’s Gambit Growth Capital, the first entirely female-led SPAC.
  • Founder and Managing Partner of Colle Capital.
  • A leading voice in the venture industry, focused on promoting data-driven management, founder diversity and ESG.
  • Over 40% of Colle’s portfolio companies have diverse management teams.
  • Formerly a Board Director at Hyliion and Doctor.com (acquired by Press Ganey), and currently on the boards of several Colle portfolio companies.
  • Prior to founding Colle Capital, served as a Partner at Wall Street Technology Partners and before that as a Director of Dresdner Kleinwort Wasserstein’s Private Equity Group.
  • Co-founded Work It, Mom!

About Lone Fønss Schrøder

  • Tenured leader of innovative logistics and technology-driven companies.
  • Currently Chief Executive Officer of blockchain technology company Concordium AG.
  • Vice Chair of the Board of Directors of Volvo Cars.
  • Board member of Ikea.
  • Areas of expertise include digital transformation, new business models, corporate strategy, bank and capital markets, sustainability and blockchain technology.
  • Holds governance positions across companies such as Aker Holdings ASA, AKSO ASA, and INGKA Holding BV.
  • Began her career at A.P. Moller Maersk A/S, where she worked for more than 20 years and held several senior positions.
  • Has served as Director in various large corporations (elected) Handelsbanken, Schneider, Valmet, Yara, Vattenfall.
  • Served as President and CEO of Wallenius Lines (2005 to 2010), a leading provider of global factory to dealer transport solutions for, among others, the automotive industry.

About Esther Dyson

  • Executive founder of Wellville, a 10-year project (2015-2024) focused on increasing health and equity in five US communities.
  • Accomplished investor, journalist, author, commentator, and philanthropist.
  • Angel investor focused on health, insurance, open government, digital technology, biotechnology, logistics, and aerospace.
  • Early investor in Swvl and other notable startups including 23andMe (former board member), Evernote (former board member), Flickr, Ilara Health, Meetup (former board member), Omada Health, ProofPilot, Square, WPP Group (former board member) and Yandex (board member).
  • Founding Chair of ICANN (Internet Corporation for Assigned Names and Numbers) from 1998 to 2000. On the boards of the Long Now Foundation, Open Corporates, and The Commons Project.
  • Author of bestselling, widely translated 1996 book “Release 2.0: A Design for Living in the Digital Age.”

About Swvl

Swvl is a global tech startup based in Dubai that provides a semi-private alternative to public transportation for individuals who cannot afford or access private options. The Company has built a parallel mass transit system offering intercity, intracity, B2B and B2G transportation in 10 megacities across Africa, Asia, and the Middle East. Swvl’s tech-enabled offerings make mobility safer, more efficient and environmentally friendly, while still ensuring that it is accessible and affordable for everyone. Customers can book their rides on an easy-to-use app with varied payment options and access high-quality private buses and vans that operate according to fixed routes, stations, times, and prices.

Swvl was co-founded by Mostafa Kandil, who began his career at Rocket Internet, where he launched the car sales platform Carmudi in the Philippines, which became the largest car classifieds company in the country in just six months. He then served as Rocket Internet’s Head of Operations. In 2016, Kandil joined Careem, a ride-sharing company and the first unicorn in the Middle East. He supported the platform’s expansion into multiple new markets. Careem is now a subsidiary of Uber, based in Dubai, with operations across 100 cities and 15 countries.

Forward-Looking Statements

Certain statements made herein are not historical facts but are forward-looking statements. Forward-looking statements generally are accompanied by words such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “should,” “would,” “plan,” “predict,” “potential,” “seem,” “seek,” “future,” “outlook” and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the proposed business combination between Swvl and Queen’s Gambit, the estimated or anticipated future results and benefits of the combined company following the business combination, including the likelihood and ability of the parties to successfully consummate the business combination, future opportunities for the combined company and other statements that are not historical facts.

These statements are based on the current expectations of Swvl and/or Queen’s Gambit’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Swvl and Queen’s Gambit. These statements are subject to a number of risks and uncertainties regarding Swvl’s business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to:  general economic, political and business conditions, including but not limited to the economic and operational disruptions and other effects of the COVID-19 pandemic; the inability of the parties to consummate the business combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement; the number of redemption requests made by Queen’s Gambit’s shareholders in connection with the business combination; the outcome of any legal proceedings that may be instituted against the parties following the announcement of the business combination; the risk that the approval of the shareholders of Swvl or Queen’s Gambit for the potential transaction is not obtained; failure to realize the anticipated benefits of the business combination, including as a result of a delay in consummating the potential transaction or additional information that may later arise in connection with preparation of the registration statement on Form F-4 and proxy materials, or after the consummation of the business combination as a result of the limited time SPAC had to conduct due diligence; the risk that the business combination disrupts current plans and operations as a result of the announcement and consummation of the business combination; the ability of the combined company to execute its growth strategy, manage growth profitably and retain its key employees; competition with other companies in the mobility industry; Swvl’s limited operating history and lack of experience as a public company; the lack of, or recent implementation of, certain policies and procedures to ensure compliance with applicable laws and regulations, including with respect to anti-bribery, anti-corruption, and cyber protection; the risk that Swvl is not able to execute its growth plan, which depends on rapid, international expansion; the risk that Swvl is unable to attract and retain consumers and qualified drivers and other high quality personnel; the risk that Swvl is unable to protect and enforce its intellectual property rights; the risk that Swvl is unable to determine rider demand to develop new offerings on its platform; the difficulty of obtaining required registrations, licenses, permits or approvals in jurisdictions in which Swvl currently operates or may in the future operate; the fact that Swvl currently operates in and intends to expand into jurisdictions that are, or have been, characterized by political instability, may have inadequate or limited regulatory and legal frameworks and may have limited, if any, treaties or other arrangements in place to protect foreign investment or involvement; the risk that Swvl’s drivers could be classified as employees, workers or quasi-employees in the jurisdictions they operate; the fact that Swvl has operations in countries known to experience high levels of corruption and is subject to territorial anti-corruption laws in these jurisdictions; the ability of Holdings to obtain or maintain the listing of its securities on a U.S. national securities exchange following the business combination; costs related to the business combination; and other risks that will be detailed from time to time in filings with the SEC. The foregoing list of risk factors is not exhaustive. There may be additional risks that Swvl presently does not know or that Swvl currently believes are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Swvl’s expectations, plans or forecasts of future events and views as of the date of this communication. Swvl anticipates that subsequent events and developments will cause Swvl’s assessments and projections to change. However, while Swvl may elect to update these forward-looking statements in the future, Swvl specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Swvl’s assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements.

Participants in the Solicitation

Holdings, Swvl, Queen’s Gambit and their respective directors, executive officers, other members of management, and employees, under SEC rules, may be deemed participants in the solicitation of proxies of Queen’s Gambit’s shareholders in connection with the business combination. Investors and security holders may obtain more detailed information regarding the names and interests in the business combination of the directors and officers of Holdings, Swvl and Queen’s Gambit in the registration statement on Form F-4 to be filed with the SEC by Holdings, which will include the proxy statement of Queen’s Gambit for the business combination. Information about Queen’s Gambit’s directors and executive officers is also available in Queen’s Gambit’s Annual Form 10-K for the fiscal year ended December 31, 2020 and other relevant materials filed with the SEC.

No Offer or Solicitation

This news release is for informational purposes only and is not a “solicitation” as defined in Section 14 of the Securities Exchange Act of 1934, as amended. This news release is neither an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities or the solicitation of any vote in any jurisdiction pursuant to the business combination or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.

Media Contact

Daniel Yunger

Kekst CNC
[email protected]
917-574-8582

Investor Contact

Youssef Salem

Swvl CFO
[email protected]

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/swvl-to-enhance-board-with-appointment-of-three-highly-accomplished-women–tech-leaders-301349460.html

SOURCE Swvl Inc.

Ribbon Communications to Present at Oppenheimer 24th Annual Technology, Internet and Communications Conference

PR Newswire

PLANO, Texas, Aug. 5, 2021 /PRNewswire/ — Ribbon Communications Inc. (Nasdaq: RBBN), a global provider of real time communications software and IP optical transport solutions to service providers, enterprises, and critical infrastructure sectors, today announced that it will be presenting at the Oppenheimer 24th Annual Technology, Internet and Communications Conference, taking place August 9-11 in a virtual format.

Bruce McClelland, President and Chief Executive Officer, and Mick Lopez, Chief Financial Officer, will be presenting at 9:55am Eastern Time on Wednesday, August 11.

The presentation will be made available live via webcast, as well as archived replay on the Investor Relations section of the Ribbon Communications website at investors.ribboncommunications.com.

About Ribbon
Ribbon Communications (Nasdaq: RBBN) delivers communications software, IP and optical networking solutions to service providers, enterprises and critical infrastructure sectors globally. We engage deeply with our customers, helping them modernize their networks for improved competitive positioning and business outcomes in today’s smart, always-on and data-hungry world. Our innovative, end-to-end solutions portfolio delivers unparalleled scale, performance, and agility, including core to edge software-centric solutions, cloud-native offers, leading-edge security and analytics tools, along with IP and optical networking solutions for 5G. To learn more about Ribbon visit rbbn.com.


Investor Relations


APAC, CALA & EMEA Press

Tom Berry

Catherine Berthier

+1 (978) 614-8050

+1 (646) 741-1974

[email protected] 

[email protected]


North American Press


Analyst Relations

Dennis Watson

Michael Cooper

+1 (214) 695-2224

+1 (708) 212-6922

[email protected] 

[email protected] 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ribbon-communications-to-present-at-oppenheimer-24th-annual-technology-internet-and-communications-conference-301349458.html

SOURCE Ribbon Communications Inc.